Boron neutron capture therapy for malignant melanoma: first clinical case report in China

A phase I/II clinical trial for treating malignant melanoma by boron neutron capture therapy (BNCT) was designed to evaluate whether the world’s first in-hospital neutron irradiator (IHNI) was qualified for BNCT. In this clinical trial planning to enroll 30 patients, the first case was treated on Au...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Zhong, Song, Zewen, Zhou, Yongmao, Liu, Tong, Zhang, Zizhu, Zhao, Yanzhong, Chen, Yang, Jin, Congjun, Chen, Xiang, Lu, Jianyun, Han, Rui, Li, Pengzhou, Sun, Xulong, Wang, Guohui, Shi, Guangqing, Zhu, Shaihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242447/
https://www.ncbi.nlm.nih.gov/pubmed/28174492
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242447/
https://www.ncbi.nlm.nih.gov/pubmed/28174492
http://dx.doi.org/10.21147/j.issn.1000-9604.2016.06.10

Ejemplares similares